Minimally important differences were estimated for six Patient-Reported Outcomes Measurement Information System-Cancer scales in advanced-stage cancer patients
about
Testing the effects of narrative and play on physical activity among breast cancer survivors using mobile apps: study protocol for a randomized controlled trial.A pilot study of patient-centered outcome assessment using PROMIS for patients undergoing colorectal surgeryPatient reported outcomes of a randomized, placebo-controlled trial of bevacizumab in the front-line treatment of ovarian cancer: a Gynecologic Oncology Group StudyA systematic review of the impact of routine collection of patient reported outcome measures on patients, providers and health organisations in an oncologic setting.Reliability and construct validity of PROMIS® measures for patients with heart failure who undergo heart transplant.PROMIS measures of pain, fatigue, negative affect, physical function, and social function demonstrated clinical validity across a range of chronic conditions.PROMIS Fatigue Item Bank had Clinical Validity across Diverse Chronic ConditionsResponsiveness to Change and Minimally Important Differences of the Patient-Reported Outcomes Measurement Information System Gastrointestinal Symptoms Scales.Report of the NIH Task Force on research standards for chronic low back painPsychometric Properties and Performance of the Patient Reported Outcomes Measurement Information System® (PROMIS®) Depression Short Forms in Ethnically Diverse GroupsComparing CESD-10, PHQ-9, and PROMIS depression instruments in individuals with multiple sclerosis.Reducing survey burden: feasibility and validity of PROMIS measures in multiple sclerosis.Feasibility of using the patient-reported outcomes measurement information system in academic health centers: case series design on pain reduction after chiropractic care.Ecological validity and clinical utility of Patient-Reported Outcomes Measurement Information System (PROMIS®) instruments for detecting premenstrual symptoms of depression, anger, and fatiguePatient-Reported Outcomes Measurement Information System (PROMIS): efficient, standardized tools to measure self-reported health and quality of life.Differential expression of genes related to mitochondrial biogenesis and bioenergetics in fatigued prostate cancer men receiving external beam radiation therapy.Mental health outcomes during colorectal cancer survivorship: a review of the literature.Supervised classification by filter methods and recursive feature elimination predicts risk of radiotherapy-related fatigue in patients with prostate cancerObesity is associated with worse quality of life in women with gynecologic malignancies: an opportunity to improve patient-centered outcomes.Associations between self-reported post-diagnosis physical activity changes, body weight changes, and psychosocial well-being in breast cancer survivorsEvaluation of the patient-reported outcomes measurement information system in a large cohort of patients with inflammatory bowel diseases.Comparing PROMIS computer-adaptive tests to the Brief Symptom Inventory in patients with prostate cancer.Psychosocial telephone counseling for survivors of cervical cancer: results of a randomized biobehavioral trialBrief versions of the FACIT-fatigue and FAACT subscales for patients with non-small cell lung cancer cachexia.Validity of two new patient-reported outcome measures in systemic sclerosis: Patient-Reported Outcomes Measurement Information System 29-item Health Profile and Functional Assessment of Chronic Illness Therapy-Dyspnea short form.Engaging Latina cancer survivors, their caregivers, and community partners in a randomized controlled trial: Nueva Vida intervention.A Comparison of the Mental Health and Well-Being of Sexual Minority and Heterosexual First-Year Medical Students: A Report From the Medical Student CHANGE Study.Factors associated with poor quality of life among cervical cancer survivors: implications for clinical care and clinical trials.Longitudinal evaluation of PROMIS-29 and FACIT-dyspnea short forms in systemic sclerosisHealth-related profiles of people with lower limb loss.Establishing a common metric for self-reported pain: linking BPI Pain Interference and SF-36 Bodily Pain Subscale scores to the PROMIS Pain Interference metricMinimal important differences for fatigue patient reported outcome measures-a systematic review.Mental Well-Being in First Year Medical Students: A Comparison by Race and Gender: A Report from the Medical Student CHANGE Study.Objectively measured physical activity and sedentary behavior and quality of life indicators in survivors of breast cancer.Initial report of the osteogenesis imperfecta adult natural history initiative.Usefulness of patients-reported outcomes in rheumatoid arthritis focus group.Mitochondria-related gene expression changes are associated with fatigue in patients with nonmetastatic prostate cancer receiving external beam radiation therapy.Child and parent preferences for graphical display of patient-reported outcome data.Feasibility, acceptability, and preliminary efficacy of a technology-assisted psychosocial intervention for racially diverse men with advanced prostate cancerEstimating minimally important difference (MID) in PROMIS pediatric measures using the scale-judgment method.
P2860
Q27311406-B33CEEB5-4BAB-4559-9430-FD6044E429F2Q30252506-B265AA38-50A6-46B3-9B37-E051CD882E23Q30411910-48CDB2E2-8E39-4E59-8D36-3B5DA951DC6BQ30541146-7A987BE5-A1BB-4158-89EE-0F76B4711DB3Q30666832-15F5D042-F94A-4B67-8B23-E2B45DFD8160Q30830391-4E48717C-9E2E-4BE8-9454-7563F9EA03FEQ33458017-B203B609-3842-498D-97E3-E7D2C1437081Q33469946-EA6FBB09-A6A9-49A8-A9F4-7252DCACEDC4Q33577714-2BA5CB83-CA71-458B-BEF6-0AFD68AF0FD1Q33724067-8F275321-CB39-44C9-BC95-D7D7A0448776Q33760818-6F7737E6-16A6-4EDF-9C27-407C9958B2BCQ33864809-63E97993-BA0B-4C41-912D-BDFD35F38912Q34168096-87D025F8-FBC6-461D-AEAA-372E6DC9D60AQ34172776-8029268A-56EB-47B9-9413-A6FDFC4D0C66Q34266078-37587C39-3E34-42DE-8ABB-2AEEF8174859Q34416073-93680888-C330-4178-9345-CF0D0B4E4952Q34491355-97F76540-AE58-4134-8C6F-2285CA41942CQ34609499-617104C3-EE7E-40E1-9B70-E12CCF36533CQ35007517-AE14E974-F316-44B2-A26F-DF26313F6B9AQ35154605-A94817C0-6D90-4017-82F3-C1C1DB40A49BQ35183164-B1015CFA-5700-4422-8B9F-A4D98833D5B4Q35211558-42804BA7-1367-4A47-AECE-7B882E7F7726Q35215047-E165FB96-1EF5-4F09-9978-D1E06EBDB10BQ35225405-EC9C0348-AABB-40E6-A397-D2A9E877F474Q35491907-724EB7AF-5F47-4EBE-B3C9-4A14C6945163Q35513416-5C286619-AA88-4A13-9F39-B1606007AD0FQ35553951-94D98CCA-8F0E-42A1-9DB7-AD9A2FF1F9E7Q35776840-711EAF53-5F8D-4C55-88A1-EE9FBF64D7BBQ35781172-87346230-1C06-47E1-98F3-3139B4188007Q35900993-D379A4E4-234B-479D-B0D6-13DB7A848074Q36052827-571706A8-6682-438B-B0CA-0C137B3B1E9EQ36069816-856145A5-00D0-48A3-BB24-6E973592AB11Q36084828-35CB814F-D209-45F1-9C5F-1FAA00F4EBCEQ36253712-AF180ACA-2A67-467A-8A98-C237B5C24283Q36292806-ADC1A590-DF2E-4F4C-802F-F68F9AB9A866Q36302285-B08FD8FA-6BBD-4165-AE7A-5F04450A888BQ36336549-201084CB-F9E7-4C30-A0E8-760B810B5E6AQ36346965-D28616FA-27B7-4A02-9F2A-88E8CF3ED065Q36348825-3563E465-D74C-4021-9704-5299123B3C82Q36414940-EEB77EA2-C418-44D0-A846-8DD607241446
P2860
Minimally important differences were estimated for six Patient-Reported Outcomes Measurement Information System-Cancer scales in advanced-stage cancer patients
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Minimally important difference ...... advanced-stage cancer patients
@ast
Minimally important difference ...... advanced-stage cancer patients
@en
Minimally important difference ...... advanced-stage cancer patients
@nl
type
label
Minimally important difference ...... advanced-stage cancer patients
@ast
Minimally important difference ...... advanced-stage cancer patients
@en
Minimally important difference ...... advanced-stage cancer patients
@nl
prefLabel
Minimally important difference ...... advanced-stage cancer patients
@ast
Minimally important difference ...... advanced-stage cancer patients
@en
Minimally important difference ...... advanced-stage cancer patients
@nl
P2093
P2860
P1476
Minimally important difference ...... advanced-stage cancer patients
@en
P2093
David T Eton
Kathleen J Yost
Sofia F Garcia
P2860
P304
P356
10.1016/J.JCLINEPI.2010.11.018
P50
P577
2011-05-01T00:00:00Z